scispace - formally typeset
D

Deborah R. Azrael

Researcher at Harvard University

Publications -  159
Citations -  7734

Deborah R. Azrael is an academic researcher from Harvard University. The author has contributed to research in topics: Poison control & Suicide prevention. The author has an hindex of 44, co-authored 140 publications receiving 6424 citations. Previous affiliations of Deborah R. Azrael include College of Health Sciences, Bahrain & RMIT University.

Papers
More filters
Journal ArticleDOI

Emotional Distress Among LGBT Youth: The Influence of Perceived Discrimination Based on Sexual Orientation

TL;DR: Mediation analyses showed that perceived discrimination accounted for increased depressive symptomatology amongLGBT males and females, and accounted for an elevated risk of self-harm and suicidal ideation among LGBT males.
Journal ArticleDOI

Household firearm ownership and rates of suicide across the 50 United States.

TL;DR: Household firearm ownership levels are strongly associated with higher rates of suicide, consistent with the hypothesis that the availability of lethal means increases the rate of completed suicide.
Journal ArticleDOI

Suicide mortality in the United States: the importance of attending to method in understanding population-level disparities in the burden of suicide.

TL;DR: Findings from ecologic and individual-level studies conducted over the past two decades illustrate the importance of accounting for the availability of highly lethal suicide methods in efforts to understand (and ultimately reduce) disparities in suicide mortality across populations.
Journal ArticleDOI

Firearm availability and unintentional firearm deaths, suicide, and homicide among 5-14 year olds.

TL;DR: A disproportionately high number of 5-14 year olds died from suicide, homicide, and unintentional firearm deaths in states and regions where guns were more prevalent.
Journal ArticleDOI

Opioid Analgesics and the Risk of Fractures in Older Adults with Arthritis

TL;DR: To compare the risk of fracture associated with initiating opioids with that of nonsteroidal anti‐inflammatory drugs (NSAIDs) and the variation in risk according to opioid dose, duration of action, and duration of use, is compared.